Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
Olema Oncology appointed Prakash Raman, Ph.D., to its Board of Directors, adding two decades of biopharmaceutical executive leadership experience. Dr. Raman currently serves as CEO of InduPro Therapeutics and previously led Ribon Therapeutics and held senior business development roles at Flagship Pioneering and Novartis.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.